BioSpace News Archive

BioMidwest

Cardio Diagnostics Holdings Inc Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease

Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD™, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.

February 28, 2023

·

7 min read

Drug Development

Kiromic BioPharma Reports Favorable Deltacel™ Preclinical Pharmacology Results

Kiromic BioPharma Reports Favorable Deltacel ™ Preclinical Pharmacology Results.

February 28, 2023

·

4 min read

Genetown

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO will present at the Canaccord Genuity Musculoskeletal Conference.

February 28, 2023

·

1 min read

Pharm Country

PAVmed Digital Health Subsidiary Veris Health’s Veris Cancer Care Platform™ Goes Live

PAVmed Inc. announced that the Veris Cancer Care Platform™, designed to enhance personalized cancer care through remote patient monitoring, is now live following successful onboarding of the first cohort of cancer patients and their clinicians.

February 28, 2023

·

6 min read

Pharm Country

Catalent Publishes Fourth Annual Corporate Responsibility Report Highlighting Achievements While Providing New Record Number of Patient Treatments

Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, published its fourth Corporate Responsibility Report for its fiscal year 2022, which ended June 30, 2022.

February 28, 2023

·

3 min read

BioCapital

MyMD Pharmaceuticals® Announces Upcoming Presentation of Preclinical Rheumatoid Arthritis Data for Oral TNF-α Inhibitor MYMD-1® at the Society of Toxicology 2023 Annual Meeting

MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”) announced that preclinical data from a study, conducted in partnership with Charles River Laboratories International, Inc., has been accepted for presentation at the upcoming Society of Toxicology (SOT) 2023 Annual Meeting.

February 28, 2023

·

4 min read

Zymeworks Announces Participation in Upcoming Investor Conferences - February 28, 2023

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences.

February 28, 2023

·

2 min read

Business

Original “Shark” and Iconic Entrepreneur Kevin Harrington Joins FSD Pharma Advisory Board

FSD Pharma Inc. today announced that iconic entrepreneur Kevin Harrington has joined the Company’s Advisory Board.

February 28, 2023

·

7 min read

FDA

FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication in the US

Jaguar Health today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to crofelemer for the indication of microvillus inclusion disease (MVID).

February 28, 2023

·

5 min read

Genetown

Anika to Participate in the Canaccord Genuity Musculoskeletal Conference - February 28, 2023

Anika Therapeutics, Inc. today announced that management will participate at the Canaccord Genuity Musculoskeletal Conference in Las Vegas, NV on Tuesday, March 7, 2023 at 3:00 p.m. PT (6:00 p.m. ET).

February 28, 2023

·

1 min read